Altair Nanotechnologies And Spectrum Pharmaceuticals, Inc. Agree To Settlement

RENO, Nev.--(BUSINESS WIRE)--June 7, 2006--Altair Nanotechnologies, Inc. (NASDAQ: ALTI - News), announced today it will receive 100,000 shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI - News) stock for a milestone payment and an additional 40,000 shares for product development improvements, with a total approximate value of $550,000, following a mutually agreed upon resolution to arbitration proceedings involving the two companies. Altairnano and Spectrum Pharmaceuticals will continue efforts to move the RenaZorb product technology to market quickly.
MORE ON THIS TOPIC